Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

bens1

AllTrials puts FDA under pressure with Trials Tracker

February 22, 2018 Medical Communications alltrials, biotech, drugs, pharma, pharmaceutical

A year to the day that the FDA unveiled its Final Rule, which sees organisation given 13 months from clinical …
News
regeneron

Reports increasing of worrying side-effects with Regeneron’s Eylea

February 22, 2018 Medical Communications, Research and Development, Sales and Marketing Eylea, FDA, Regeneron, pharma

Reports are emerging which detail some pretty alarming side-effects in patients receiving Regeneron’s blockbuster eye drug Eylea: once injected into …
News
greek_parliament

Greek parliament moves to investigate 10 politicians

February 22, 2018 Medical Communications, Sales and Marketing Greece, Greek Parliament, Novartis, biotech, drugs, pharma, pharmaceutical

After a 20-hour debate, Greek parliament has voted in favour of investigating 10 politicians named as part of an investigation …
News
img_9530_resized

Patient experience: Living with multiple myeloma

February 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …
Feature
top_ten

Top Ten most popular articles on Pharmafile.com this week

February 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical

Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …
News
zappys_technology_solutions

Ovarian cancer risk may be inherited from the father, research indicates

February 16, 2018 Medical Communications, Research and Development Cancer, Roswell Park Comprehensive Cancer Centre, ovarian cancer

Researchers at the Roswell Park Comprehensive Cancer Centre in New York have published findings indicating that ovarian cancer risk may …
News
fda_building_web

FDA weighs up divisive change to Alzheimer’s drug assessment

February 16, 2018 Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical

Alzheimer’s disease (AD) is an area badly in need of a treatment, the problem is that this prospect seems to …
News

Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health

February 16, 2018 Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma

Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …
News
stem-cell-163711_960_720

Silicon Valley-backed Celgene spin-off launches with $250m

February 16, 2018 Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical

Biotechs are known for getting off the ground early with serious levels of financing, often based more on the acumen …
News
network-1989146_960_720

Taking a look behind the scenes of Serialisation

February 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
Feature
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
Appointment
gsk_wall

SFO bribery investigation into GSK opens old wounds

February 9, 2018 Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
News
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018 Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
News

FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer

February 9, 2018 Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma

Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026